Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Total 13F shares
-
11,121,954
-
Share change
-
+280,756
-
Total reported value
-
$62,947,464
-
Price per share
-
$5.65
-
Number of holders
-
27
-
Value change
-
+$1,581,064
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2019
As of 31 Dec 2019,
scPharmaceuticals Inc. - Common Stock (SCPH) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,121,954 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., Eversept Partners, LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Squarepoint Ops LLC, and Alambic Investment Management, L.P..
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.